Free Trial

Contineum Therapeutics (CTNM) Stock Trends and Sentiment

$16.31
+0.19 (+1.18%)
(As of 06/7/2024 ET)

Media Mentions Over Time

MarketBeat New Followers Over Time

MarketBeat Searches Over Time



Page Views Over Time



Recieve Contineum Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for CTNM and its competitors with MarketBeat's FREE daily newsletter.

CTNM Social Media Mentions

Related Companies and Tools

This page (NASDAQ:CTNM) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners